On World Obesity Day, the public health doctor says while much is changing around drugs and weight loss, we cannot lose sight ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

Australian telehealth startup Eucalyptus has made $200 million in 18 months as demand for weight loss drugs soars. Here's how ...

AbbVie inked a licensing deal Monday worth up to $2.23 billion for an amylin-targeting obesity treatment from Denmark-based ...

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...

You've probably heard about the relatively new weight loss medications and the results some people have seen with them and you may have wondered if they could help you.

What about the side-effects? Will I regain all my weight? Dr Sarah Jarvis has the answers to your burning questions.

AbbVie is entering the obesity treatment market with a $2.3bn licensing agreement to acquire rights to a long-acting amylin ...

The FDA has declared that the shortage of popular weight-loss drugs, including Ozempic and Wegovy, is officially over.

A licensing deal with Denmark’s Gubra gives the immunology giant control of an experimental therapy that could compete with ...